JP2000300654A - Water gel medicine volatilizer - Google Patents

Water gel medicine volatilizer

Info

Publication number
JP2000300654A
JP2000300654A JP11113719A JP11371999A JP2000300654A JP 2000300654 A JP2000300654 A JP 2000300654A JP 11113719 A JP11113719 A JP 11113719A JP 11371999 A JP11371999 A JP 11371999A JP 2000300654 A JP2000300654 A JP 2000300654A
Authority
JP
Japan
Prior art keywords
water gel
water
drug
volatilization
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP11113719A
Other languages
Japanese (ja)
Other versions
JP4111364B2 (en
Inventor
Hiroshi Kato
弘 加藤
Hiromi Nakagawa
宏美 中川
Rihachi Kitamura
利八 北村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
T Hasegawa Co Ltd
Original Assignee
T Hasegawa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by T Hasegawa Co Ltd filed Critical T Hasegawa Co Ltd
Priority to JP11371999A priority Critical patent/JP4111364B2/en
Publication of JP2000300654A publication Critical patent/JP2000300654A/en
Application granted granted Critical
Publication of JP4111364B2 publication Critical patent/JP4111364B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To provide a water gel medicine volatilizer which is capable of constantly volatilizing a medicine with good balance from the start of volatilization to the end of the volatilization and is capable of preventing the degradation in medicine effects, such as the intensity of the medicine with lapse of time, diffusivity, persistence, etc. SOLUTION: The water gel medicine volatilizer is prepared by compounding an acrylic acid-alkyl methacrylate (10C-30C) copolymer and a gelatinizing agent. The medicine is at least one kind selected from perfumes, deodorants, insectifuges, insecticides, sterilizing agents and repellents.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、香料、消臭剤、防
虫剤、殺虫剤、除菌剤、忌避剤などの薬剤を含有する水
ゲル薬剤揮散体に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a water gel drug volatile containing a fragrance, a deodorant, an insect repellent, an insecticide, a disinfectant, a repellent, and the like.

【0002】[0002]

【従来の技術】室内や自動車の車内等に用いられる芳香
剤・消臭剤等として、薬剤揮散体が利用されてきた。水
ゲル薬剤揮散体は、水性液体型、油性液体型、固形型等
のタイプの薬剤揮散体に比べ一般に安価に製造でき、し
かも、揮散後の明確な収縮終点を持たせることが可能で
あるため、最近注目されてきている。このような水ゲル
薬剤揮散体としては、例えば、ゲル化剤として、カラギ
ーナン、ジェランガム、寒天を使用したものが提案され
ている(特開昭54−135229号公報、特開昭60
−135058号公報、特開昭62−41661号公
報、特開昭64−40542号公報、特開平1−742
39号公報、特開平2−144067号公報参照)。し
かしながら従来の水ゲル薬剤揮散体は、揮散時に揮散媒
体物質である水の揮散量が経日に伴って減少していく傾
向にあり、この水の揮散量の減少が薬剤の揮散強度、拡
散性、持続性等の薬剤効果を低下させることになり問題
となっている。
2. Description of the Related Art Pharmaceutical vaporizers have been used as fragrances and deodorants for use indoors, in automobiles, and the like. Water gel drug volatiles can be generally manufactured at a lower cost than aqueous liquid type, oily liquid type, solid type, etc. types of drug volatiles, and can have a clear contraction end point after volatilization. , Has been attracting attention recently. As such a water gel drug volatile, for example, those using carrageenan, gellan gum, and agar as gelling agents have been proposed (Japanese Patent Application Laid-Open Nos. 54-135229 and 60).
JP-A-135058, JP-A-62-41661, JP-A-64-40542, JP-A-1-742
39, JP-A-2-140407). However, in conventional water-gel drug volatilizers, the volatilization amount of water, which is a volatile medium substance, tends to decrease over time during volatilization. In addition, there is a problem in that the effect of the drug such as sustainability is reduced.

【0003】[0003]

【発明が解決しようとする課題】従って本発明の目的
は、揮散開始から揮散終了時まで薬剤をコンスタントに
バランスよく揮散することができ、経日による薬剤の強
度、拡散性、持続性等の薬剤効果の低下を防止すること
ができる水ゲル薬剤揮散体を提供するにある。
SUMMARY OF THE INVENTION Accordingly, an object of the present invention is to provide a medicine capable of volatilizing the medicine in a well-balanced manner from the start of volatilization to the end of the volatilization, and to improve the strength, diffusibility, sustainability and the like of the medicine over time. It is an object of the present invention to provide a water gel drug volatilizer capable of preventing the effect from decreasing.

【0004】[0004]

【課題を解決するための手段】上記の課題を解決するた
めに、本発明は、アクリル酸・メタクリル酸アルキル
(C10〜C30)共重合体およびゲル化剤を配合して
水ゲル薬剤揮散体とする。また、薬剤が香料、消臭剤、
防虫剤、殺虫剤、除菌剤および忌避剤から選択される少
なくとも1種以上である。
SUMMARY OF THE INVENTION In order to solve the above-mentioned problems, the present invention provides a water-gel drug volatile by blending an acrylic acid / alkyl methacrylate (C10-C30) copolymer and a gelling agent. I do. In addition, medicine is fragrance, deodorant,
At least one selected from insect repellents, insecticides, disinfectants and repellents.

【0005】[0005]

【発明の実施の形態】本発明者らは、上記のごとき従来
型の水ゲル薬剤揮散体について、その欠点を解決すべく
鋭意研究を行った。その結果、水ゲル薬剤揮散体を製造
するに際して、アクリル酸・メタクリル酸アルキル(C
10〜C30)共重合体およびゲル化剤を添加調製する
ことにより、揮散開始から揮散終了時まで薬剤をコンス
タントに揮散することができ、経日による薬剤の揮散強
度、拡散性、持続性等の薬剤効果の低下を防止すること
ができるという事実を見いだし、本発明を完成するに至
った。
BEST MODE FOR CARRYING OUT THE INVENTION The present inventors have conducted intensive studies on the conventional water gel drug volatiles as described above in order to solve the drawbacks. As a result, when producing a water gel drug volatile, an acrylic acid / alkyl methacrylate (C
10-C30) By adding and preparing a copolymer and a gelling agent, the drug can be volatilized constantly from the start of volatilization to the end of volatilization, and the volatilization strength, diffusivity, durability and the like of the drug over time can be improved. The inventors have found that a reduction in drug effect can be prevented, and have completed the present invention.

【0006】尚、本発明の水ゲル薬剤揮散体に使用され
るアクリル酸・メタクリル酸アルキル(C10〜C3
0)共重合体は、高分子の乳化剤で、これまでクリーム
や乳液などのフェイスケア製品をはじめ、ハンドケア製
品、ヘアケア製品、ボディケア製品、サンスクリーン製
剤などへの応用例が知られているが(フレグランス ジ
ャーナル,VOL.26,NO.8,P.79〜83,
1998)、水ゲル薬剤揮散体へ応用したのは本発明者
らが初めてである。
[0006] The acrylic acid / alkyl methacrylate (C10 to C3) used in the water gel drug vaporizer of the present invention.
0) Copolymers are high molecular emulsifiers, and have been applied to face care products such as creams and emulsions, as well as hand care products, hair care products, body care products, and sunscreen preparations. (Fragrance Journal, Vol. 26, No. 8, P. 79-83,
1998), the present inventors are the first to apply to a water gel drug vaporizer.

【0007】本発明の水ゲル薬剤揮散体に使用されるア
クリル酸・メタクリル酸アルキル(C10〜C30)共
重合体は乳化作用を有するため、従来の水ゲル薬剤揮散
体に使用されている界面活性剤を全く使用しないか、又
は界面活性剤の使用量を減ずることができ、界面活性剤
による地球環境問題に対応できる。また、本発明の水ゲ
ル薬剤揮散体は、水の揮散量がコンスタントであるた
め、揮散終了時の残渣形状・量が従来品より小さくな
り、揮散体の終点が目視で容易に判定することができる
などの効果を有する水ゲル薬剤揮散体が提供される。
[0007] The copolymer of acrylic acid and alkyl methacrylate (C10 to C30) used in the water gel drug vaporizer of the present invention has an emulsifying action, so that the surfactant used in the conventional water gel drug vaporizer is used. No agent is used, or the amount of surfactant used can be reduced, and it is possible to cope with global environmental problems caused by surfactants. In addition, the volatilized water gel agent of the present invention has a constant water volatilization amount, so the residue shape and amount at the end of volatilization are smaller than conventional products, and the end point of the volatilized body can be easily determined visually. Thus, there is provided a water gel drug vaporizer having an effect of being able to do so.

【0008】以下、本発明の水ゲル薬剤揮散体の各成分
について説明する。本発明の水ゲル薬剤揮散体における
薬剤としては、水ゲル薬剤揮散体の用途に基づいて選択
される。例えば、香料、消臭剤、防虫剤、殺虫剤、除菌
剤、忌避剤などの1種または2種以上の添加成分を挙げ
ることができ、その使用量は特に制限されるものではな
く、例えば、水ゲル薬剤揮散体全体に対して約0.01
〜15重量%、好ましくは約0.1〜10重量%を例示
することができる。0.01重量%より少ない量では薬
剤の効果が十分に発揮できず、15重量%より多い量で
はコスト高となったり、水ゲルの安定性が保てないなど
の不都合がある。
Hereinafter, each component of the water gel drug volatile of the present invention will be described. The drug in the water gel drug vaporizer of the present invention is selected based on the use of the water gel drug vaporizer. For example, one or more additional components such as a fragrance, a deodorant, an insect repellent, an insecticide, a disinfectant, and a repellent can be used, and the amount of use is not particularly limited. About 0.01% based on the whole water gel
To 15% by weight, preferably about 0.1 to 10% by weight. If the amount is less than 0.01% by weight, the effect of the drug cannot be sufficiently exerted. If the amount is more than 15% by weight, the cost is increased and the stability of the water gel cannot be maintained.

【0009】本発明の水ゲル薬剤揮散体に使用されるア
クリル酸・メタクリル酸アルキル(C10〜C30)共
重合体は、アクリル酸とメタクリル酸アルキル(C10
〜C30)とを、過酸化ベンゾイル等を重合開始剤とし
て、重合させることにより得ることができる。アクリル
酸とメタクリル酸アルキルの比を変えることにより、様
々な親水性・親油性バランスの共重合体が得られる。上
記のように製造することに替えて、既に市販されている
ものを利用することもできる。この様な市販品として
は、グッドリッチ社製のペミュレンTR−1やペミュレ
ンTR−2等を例示することができる。
The copolymer of acrylic acid and alkyl methacrylate (C10 to C30) used in the water gel drug volatile of the present invention comprises acrylic acid and alkyl methacrylate (C10
To C30) can be obtained by polymerizing benzoyl peroxide or the like as a polymerization initiator. By changing the ratio of acrylic acid to alkyl methacrylate, copolymers having various balances of hydrophilicity and lipophilicity can be obtained. Instead of manufacturing as described above, commercially available products can also be used. Examples of such commercially available products include Pemulen TR-1 and Pemulen TR-2 manufactured by Goodrich.

【0010】本発明の水ゲル薬剤揮散体に使用されるア
クリル酸・メタクリル酸アルキル(C10〜C30)共
重合体の使用量は、特に制限されないが、例えば、水ゲ
ル薬剤揮散体全体に対して約0.01〜10重量%、好
ましくは約0.1〜5重量%を挙げることができる。
0.01重量%より少ない量では薬剤の効果が十分に発
揮できず、10重量%より多い量ではコスト高となった
り、粘度が高くなり水ゲルの調製が難しくなるという難
点がある。
The amount of the acrylic acid / alkyl methacrylate (C10 to C30) copolymer used in the water gel drug vaporizer of the present invention is not particularly limited. About 0.01 to 10% by weight, preferably about 0.1 to 5% by weight.
If the amount is less than 0.01% by weight, the effect of the drug cannot be sufficiently exerted. If the amount is more than 10% by weight, the cost is increased, and the viscosity becomes high, so that it is difficult to prepare a water gel.

【0011】本発明の水ゲル薬剤揮散体に用いるゲル化
剤としては、一般に水ゲル薬剤揮散体に使用されている
ものを採用することができ、例えば、カラギーナン、ジ
ェランガム、寒天、ゼラチン等の天然系ゲル化剤;イソ
ブチレン−無水マレイン酸共重合体等の合成ゲル化剤な
どを例示することができる。ゲル化剤の使用量は、特に
限定されないが、水ゲル薬剤揮散体全体に対して、例え
ば、約0.1〜15重量%を挙げることができる。0.
1重量%より少ないとゲル化が十分でなく、15重量%
より多い量では粘度が高くなり水ゲルの調製が難しくな
る。
As the gelling agent used in the water gel chemical vaporizer of the present invention, those generally used in water gel chemical vaporizers can be used. For example, natural gelling agents such as carrageenan, gellan gum, agar and gelatin can be used. Synthetic gelling agents such as isobutylene-maleic anhydride copolymer and the like. The use amount of the gelling agent is not particularly limited, but may be, for example, about 0.1 to 15% by weight based on the whole water gel drug volatile. 0.
If it is less than 1% by weight, gelation is not sufficient, and 15% by weight
If the amount is larger, the viscosity becomes high and the preparation of the water gel becomes difficult.

【0012】本発明の水ゲル薬剤揮散体に用いられる水
としては、脱イオン水、蒸留水、イオン交換水等の精製
水を用いるのが好ましい。水は基本的には残部である
が、水の使用量は、得られる水ゲル薬剤揮散体の総量を
100重量%とした場合に、通常約40〜95重量%を
例示することができる。
As the water used for the water gel drug volatile of the present invention, it is preferable to use purified water such as deionized water, distilled water and ion-exchanged water. Water is basically the balance, but the amount of water used is usually about 40 to 95% by weight, assuming that the total amount of the obtained water gel drug volatiles is 100% by weight.

【0013】本発明の水ゲル薬剤揮散体には、上記の成
分のほかに、通常水ゲル薬剤揮散体に使用される成分を
配合することができる。それらの成分としては、例え
ば、アルコール類、グリコール類、グリコールエーテル
類、ポリオール類、置換アルコール類などの溶剤類;ロ
ーカストビーンガム、キサンタンガム等の天然系高分子
物質、セルロース、ポリビニルアルコール等の合成高分
子物質などのゲル補強剤;脂肪酸石鹸、アルキル硫酸塩
等の陰イオン界面活性剤、POEアルキルエーテル、P
OEアルキルフェノール、POEソルビタンアルキレー
ト等の非イオン界面活性剤、第四級アンモニウム塩等の
陽イオン界面活性剤などの界面活性剤;水溶性染料、蛍
光染料、天然色素、無機顔料などの色素類;メチルパラ
ペン等のパラペン類、安息香酸塩類などの防腐剤;水酸
化ナトリウム、水酸化カリウム等の無機アルカリ、トリ
エタノールアミン、2−アミノ−2−メチル−1,3−
プロパンジオール等の有機アルカリなどの中和剤;塩化
カルシウム、乳酸カルシウム、塩化カリウムなどの塩類
および紫外線吸収剤などを挙げることができる。
[0013] In addition to the above-mentioned components, components usually used for water gel drug volatiles can be blended into the water gel drug volatile of the present invention. Examples of such components include solvents such as alcohols, glycols, glycol ethers, polyols, and substituted alcohols; natural polymer substances such as locust bean gum and xanthan gum; and synthetic polymers such as cellulose and polyvinyl alcohol. Gel reinforcing agents such as molecular substances; anionic surfactants such as fatty acid soaps and alkyl sulfates; POE alkyl ethers;
Surfactants such as nonionic surfactants such as OE alkylphenol and POE sorbitan alkylate, and cationic surfactants such as quaternary ammonium salts; pigments such as water-soluble dyes, fluorescent dyes, natural pigments, and inorganic pigments; Preservatives such as parapenes such as methyl parapen and benzoates; inorganic alkalis such as sodium hydroxide and potassium hydroxide; triethanolamine; 2-amino-2-methyl-1,3-
Neutralizing agents such as organic alkalis such as propanediol; salts such as calcium chloride, calcium lactate and potassium chloride; and ultraviolet absorbers.

【0014】本発明の水ゲル薬剤揮散体は、例えば、次
のように製造するのが好ましい。即ち、まず、水にゲル
化剤を加えて、一般的には室温から100℃にて加熱溶
解した後、薬剤およびアクリル酸・メタクリル酸アルキ
ル(C10〜C30)共重合体を添加して混合し、分散
液を得る。次いで、この分散液を揮散容器に充填し、冷
却ないし放冷することにより固化させる。
The water gel drug volatile of the present invention is preferably produced, for example, as follows. That is, first, a gelling agent is added to water and dissolved by heating generally at room temperature to 100 ° C., and then a drug and an acrylic acid / alkyl methacrylate (C10 to C30) copolymer are added and mixed. , To obtain a dispersion. Next, the dispersion is filled in a volatilization container, and solidified by cooling or cooling.

【0015】[0015]

【実施例】次に実施例および比較例を挙げて本発明をさ
らに具体的に説明する。 [実施例1]脱イオン水91.475gにカラギーナ
ン:X−5189(新田ゼラチン社製)2gおよびメチ
ルパラベン0.2gを添加して90℃に加熱溶解した
後、キンモクセイ香料:No.2569(長谷川香料社
製)6gとアクリル酸・メタクリル酸アルキル(C10
〜C30)共重合体:ペミュレンTR−1(グッドリッ
チ社製)0.225gおよび2−アミノ−2−メチル−
1,3−プロパンジオール(AMPD)0.1gを混合
したものを、上記の加熱溶解液に添加し、攪拌混合す
る。その後、芳香剤容器に充填して、空気中で放冷して
固化させて、本発明の水ゲル薬剤揮散体を製造した。
Next, the present invention will be described more specifically with reference to examples and comparative examples. [Example 1] Mud on water 91.475g carrageenan: X-5189 dissolved by heating in addition to 90 ° C. The (manufactured by Nitta Gelatin Inc.) 2 g and methylparaben 0.2 g, osmanthus fragrance: No. 669 of 2569 (manufactured by Hasegawa Koryo Co., Ltd.) and alkyl acrylate / alkyl methacrylate (C10
To C30) Copolymer: 0.225 g of Pemulen TR-1 (manufactured by Goodrich) and 2-amino-2-methyl-
A mixture obtained by mixing 0.1 g of 1,3-propanediol (AMPD) is added to the above heated solution, and the mixture is stirred and mixed. Thereafter, the mixture was filled in a fragrance container, allowed to cool in air, and solidified, thereby producing the water gel drug volatile of the present invention.

【0016】[実施例2]実施例1において、脱イオン
水91.475gを91.175gとし、更に、界面活
性剤:ツィーン60(ICI SURFACTANTS
社製:モノステアリン酸ポリオキシエチレンソルビタ
ン)0.3gを加えた以外は実施例1と同様に処理し
て、本発明の水ゲル薬剤揮散体を製造した。
Example 2 In Example 1, 91.475 g of deionized water was changed to 91.175 g, and a surfactant: Tween 60 (ICI SURFACTANTS) was used.
(Manufactured by K.K .: polyoxyethylene sorbitan monostearate) except that 0.3 g was added to produce a water gel drug vaporizer of the present invention.

【0017】[実施例3]実施例1において、キンモク
セイ香料をクロトン酸オクチル含有消臭液2gとし、脱
イオン水、ペミュレンTR−1、AMPDを表1に示す
量に替えた以外は実施例1と同様に処理して、本発明の
水ゲル薬剤揮散体を製造した。
Example 3 Example 1 was the same as Example 1 except that the perfume flavor was changed to 2 g of octyl crotonate-containing deodorant and deionized water, Pemulen TR-1, and AMPD were changed to the amounts shown in Table 1. In the same manner as in the above, a water gel drug volatile of the present invention was produced.

【0018】[比較例1]実施例1において、脱イオン
水91.475gを91.2gとして、ペミュレンTR
−1(前出)0.225gおよび2−アミノ−2−メチ
ル−1,3−プロパンジオール0.1gに替えて、ツィ
ーン60(前出)を0.6g使用した以外は実施例1と
同様に処理して、水ゲル薬剤揮散体を製造した。以上の
実施例1〜3,比較例1の配合成分を表1に示す。
[Comparative Example 1] In Example 1, 91.475 g of deionized water was used as 91.2 g, and Pemulen TR was used.
Same as Example 1 except that 0.6 g of Tween 60 (supra) was used instead of 0.225 g of -1 (supra) and 0.1 g of 2-amino-2-methyl-1,3-propanediol. To produce a water gel drug vaporizer. Table 1 shows the components of Examples 1 to 3 and Comparative Example 1.

【0019】[0019]

【表1】 [Table 1]

【0020】得られた水ゲル薬剤揮散体について、週毎
の1日当たりの揮散量の変化、官能試験による評価(実
施例3を除く)を行った。試験方法は以下の通りであ
り、結果を表2、表3に示す。 揮散量(g/日)の変化 水ゲル薬剤揮散体容器の開口部を一定に開口して、室温
で試料を揮散させる。経日毎の揮散重量を測定し、週毎
に1日あたりの揮散量を平均して求めた。単位はg/日
である。また、5週経過後の揮散体の残存容積の割合を
(揮散体の残存容積/調製直後の揮散体の容積×10
0)で求めた。 官能評価 水ゲル薬剤揮散体について、経日における香気の強さに
関して、よく訓練されたパネル15名にて官能評価を行
った。各人が5点法で評価し、その平均を以て、各水ゲ
ル薬剤揮散体のその日の強さとした。数値が高いほど香
気が強いことを示す。
With respect to the obtained water gel drug volatiles, the change in the amount of volatilization per day per week and the evaluation by a sensory test (excluding Example 3) were performed. The test method is as follows, and the results are shown in Tables 2 and 3. Change in volatilization amount (g / day) The opening of the water gel drug volatilizer container is constantly opened, and the sample is volatilized at room temperature. The amount of volatilization every day was measured, and the amount of volatilization per day was averaged for each week. The unit is g / day. In addition, the ratio of the remaining volume of the volatilized body after the lapse of 5 weeks was calculated as (remaining volume of the volatile body / volume of the volatilized body immediately after preparation × 10
0). Sensory evaluation The water gel drug volatiles were subjected to sensory evaluation by 15 well-trained panels regarding the intensity of aroma over time. Each person evaluated using the 5-point method, and the average was taken as the strength of each water gel drug vaporizer on that day. The higher the value, the stronger the aroma.

【0021】[0021]

【表2】 [Table 2]

【0022】[0022]

【表3】 [Table 3]

【0023】表2から明らかなように、本発明の実施例
のものは、4週目までの1日の揮散量がコンスタントで
あるのに対して、比較例1では2週目から1日あたりの
揮散量が少なくなっていた。一方、5週目の1日あたり
の揮散量は、本発明の実施例のものでは、4週目までに
比べ極端に少なくなり、ほぼ終点に達していることを示
しているのに比べ、比較例1では5週目でも徐々に揮散
しているため、終点がはっきりしなかった。表3から明
らかなように、本発明の水ゲル薬剤揮散体は、比較例の
ものに比べて、スタートから第4週までは香気が強く、
コンスタントに香気が揮散していた。
As is clear from Table 2, in the example of the present invention, the amount of volatilization per day up to the fourth week is constant, while in Comparative Example 1, the amount of volatilization per day is from the second week. Volatilization was reduced. On the other hand, the amount of volatilization per day in the fifth week was extremely smaller in the example of the present invention than in the fourth week, indicating that the end point was almost reached. In Example 1, the end point was not clear because the volatilization gradually occurred even in the fifth week. As is evident from Table 3, the water gel drug volatile of the present invention has a strong aroma from the start to the fourth week, compared to the comparative example.
The aroma was constantly evaporating.

【0024】[0024]

【発明の効果】本発明の水ゲル薬剤揮散体は、香料、消
臭剤、防虫剤などの薬剤を揮散開始から終了時までコン
スタントにバランスよく揮散でき、経日による薬剤の揮
散強度、拡散性、持続性などの薬剤効果の低下を防止す
ることができる。また、本発明の水ゲル薬剤揮散体に使
用されるアクリル酸・メタクリル酸アルキル(C10〜
C30)共重合体は乳化作用を有するため、従来の水ゲ
ル薬剤揮散体に使用されている界面活性剤を全く使用し
ないか、又は界面活性剤の使用量を減ずることができ、
界面活性剤による地球環境問題に対応でき、また更に、
本発明の水ゲル薬剤揮散体は、水の揮散量がコンスタン
トであるため、揮散終了時の残査形状が従来品より小さ
くなり、揮散体の終点が目視で容易に判定することがで
きるなどの効果を有する。
EFFECTS OF THE INVENTION The water gel chemical vaporizer of the present invention can volatilize chemicals such as fragrances, deodorants and insect repellents in a well-balanced manner from the start to the end of volatilization. In addition, it is possible to prevent a decrease in drug effects such as sustainability. In addition, the acrylic acid / alkyl methacrylate (C10 to C10) used in the water gel drug volatile of the present invention.
C30) Since the copolymer has an emulsifying effect, it is possible to use no surfactant used in conventional water gel drug volatiles or to reduce the amount of surfactant used,
Can respond to global environmental problems with surfactants.
Since the volatilized water gel of the present invention has a constant water volatilization amount, the residual shape at the end of volatilization is smaller than conventional products, and the end point of the volatilized body can be easily determined visually. Has an effect.

フロントページの続き (72)発明者 北村 利八 東京都中央区日本橋本町4丁目4番14号 長谷川香料株式会社フレグランス研究所内 Fターム(参考) 4C080 AA03 BB02 BB03 BB05 BB07 BB08 BB10 CC01 HH06 JJ03 KK03 LL06 LL09 MM31 NN23 NN26 4H011 AA02 AC01 AC06 BA01 BB22 BC18 BC19 DA17 DF03 DG03 DH02 DH10 DH20 Continuation of the front page (72) Inventor Toshihachi Kitamura 4-4-1, Nihonbashi-Honcho, Chuo-ku, Tokyo Fragrance Research Laboratories, Inc. Fragrance Research Laboratories, Hasegawa Inc. 4C080 AA03 BB02 BB03 BB05 BB07 BB08 BB10 CC01 HH06 JJ03 KK03 LL06 LL09 MM31 NN23 NN26 4H011 AA02 AC01 AC06 BA01 BB22 BC18 BC19 DA17 DF03 DG03 DH02 DH10 DH20

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】アクリル酸・メタクリル酸アルキル(C1
0〜C30)共重合体およびゲル化剤を配合してなる水
ゲル薬剤揮散体。
1. An alkyl acrylate / alkyl methacrylate (C1
0-C30) A water gel drug volatile containing a copolymer and a gelling agent.
【請求項2】薬剤が香料、消臭剤、防虫剤、殺虫剤、除
菌剤および忌避剤から選択される少なくとも1種以上で
ある、請求項1に記載された水ゲル薬剤揮散体。
2. The water gel drug vaporizer according to claim 1, wherein the drug is at least one selected from fragrances, deodorants, insect repellents, insecticides, disinfectants and repellents.
JP11371999A 1999-04-21 1999-04-21 Water gel chemical volatilizer Expired - Fee Related JP4111364B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11371999A JP4111364B2 (en) 1999-04-21 1999-04-21 Water gel chemical volatilizer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11371999A JP4111364B2 (en) 1999-04-21 1999-04-21 Water gel chemical volatilizer

Publications (2)

Publication Number Publication Date
JP2000300654A true JP2000300654A (en) 2000-10-31
JP4111364B2 JP4111364B2 (en) 2008-07-02

Family

ID=14619419

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11371999A Expired - Fee Related JP4111364B2 (en) 1999-04-21 1999-04-21 Water gel chemical volatilizer

Country Status (1)

Country Link
JP (1) JP4111364B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005198861A (en) * 2004-01-16 2005-07-28 Soda Aromatic Co Ltd Sustained-release gel form composition of volatile substance
JP2006320711A (en) * 2005-04-21 2006-11-30 Kao Corp Deodorant
JP2006320712A (en) * 2005-04-21 2006-11-30 Kao Corp Deodorant composition
WO2012017615A1 (en) 2010-08-05 2012-02-09 Takasago International Corporation Aqueous gel composition of drug volatilization body

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005198861A (en) * 2004-01-16 2005-07-28 Soda Aromatic Co Ltd Sustained-release gel form composition of volatile substance
JP2006320711A (en) * 2005-04-21 2006-11-30 Kao Corp Deodorant
JP2006320712A (en) * 2005-04-21 2006-11-30 Kao Corp Deodorant composition
JP4590369B2 (en) * 2005-04-21 2010-12-01 花王株式会社 Deodorants
JP4590370B2 (en) * 2005-04-21 2010-12-01 花王株式会社 Deodorant composition
WO2012017615A1 (en) 2010-08-05 2012-02-09 Takasago International Corporation Aqueous gel composition of drug volatilization body

Also Published As

Publication number Publication date
JP4111364B2 (en) 2008-07-02

Similar Documents

Publication Publication Date Title
JP4183830B2 (en) Alcohol-based antimicrobial composition having a cosmetic appearance
JP3357388B2 (en) Thickeners for products for topical applications
DE60119693T2 (en) TENSID-FREE TOPICAL COMPOSITIONS AND METHOD FOR THE FAST MANUFACTURE THEREOF
JP3167645B2 (en) Compositions for topical use in the form of surfactant-free oil-in-water emulsions containing neutralized crosslinked poly (2-acrylamido-2-methylpropanesulfonic acid)
US6465402B1 (en) Composition in the form of an oil-in-water emulsion and its uses in particular its cosmetic uses
DE69730621T2 (en) HYDRO-ALCOHOLIC COMPOSITIONS THAT ARE COMPRESSED BY COMPLEXES OF BORDER-ACTIVE COMPOUNDS WITH POLYMERS
JP4713586B2 (en) Composition for sustained release of volatile materials
CA2230727A1 (en) Responsive polymer networks and methods of their use
JPH09502206A (en) Topical composition containing a thickening agent
JPH08176587A (en) Perfume composition
JP2011032249A (en) Oil-in-water type emulsion composition
JPH06503566A (en) Gel-type composition with improved oil control properties
JP2000300654A (en) Water gel medicine volatilizer
JP3560628B2 (en) Self-tanning cosmetics
KR101219968B1 (en) Skin cooling compositions
JP3020354B2 (en) Hair cosmetics
JPS6242912A (en) Massage cosmetic
JP2007119556A (en) Transparent gelling agent composition, transparent gel and method for preparing transparent gel
JP2001181164A (en) Preparation for external use
US20040120975A1 (en) Biliquid foam emulsions of water and hydrofluoroether as cosmetic carriers
JPH05331033A (en) Gelatinous insect repellent
EP2057232B1 (en) Aqueous compositions
JP2001354820A (en) Composite emulsion and cosmetic formulated with the emulsion
JP2001058936A (en) Cosmetic comprising granule formulated therein
JP2002516617A (en) Reactive polymer network and use thereof

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060302

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080109

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080115

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080310

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080402

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080403

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110418

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110418

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120418

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130418

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130418

Year of fee payment: 5

LAPS Cancellation because of no payment of annual fees